Live Webinar: Where does Direct-to-Patient fit in a post Covid world?

The impact of the COVID-19 pandemic has propelled a historic and transformational shift in the clinical research industry, transforming clinical trials. This has meant finding alternative ways of working, such as utilizing new routes and adjusting study protocols, including a rise in demand for direct-to-patient delivery.

In this webinar we take a look at the premise of this model, how investigational medicinal products (IMP) or drugs are administered in the patient’s home, and the challenges and risks involved. 

Register now to attend the live event, learn from World Courier and Medical Research Network industry experts and discover how Direct-to-Patient services continue to experience significant growth. The session will be followed by a live Q&A with the speakers and all attendees will receive a copy of the recording to listen on-demand.